ArticleCPT: pharmacometrics & systems pharmacology2024
A mechanistic PK/PD model of AZD0171 (anti-LIF) to support Phase II dose selection.
Azar Shahraz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it